Brazil’s federal health regulator Anvisa plans to ask major vaccine producers to inform about the possible risks of Guillain-Barré syndrome, which is among the rarest side effects of coronavirus vaccination.
According to Anvisa, at least 34 cases of the syndrome have been detected as of today — 27 related to AstraZeneca, four to CoronaVac, and three to single-shot Janssen vaccines. Guillain-Barré syndrome is a rare autoimmune neurological disorder which can cause the immune system to attack nerve cells.
However, cases associated with the vaccines administered in Brazil are “rare,” said the regulators, adding that they only want to certify that the information is properly labeled.
The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…
Pelé, Ronaldo, Zico, Marta … All of Brazil’s truly immortal sporting icons are footballers, that…
Speaking before a Senate hearing on Tuesday, Chief of Staff Rui Costa admitted that Brazil…
New job market data from the Brazilian Institute of Geography and Statistics (IBGE) show the…
Brazil officially had 5.83 million domestic workers in 2022 — almost the entire population of…
Brazil’s Ministry of Health this month announced a purchase of 12.5 million doses of Moderna’s…